LRVHealth

LRVHealth is a venture capital firm founded in 2000 and based in Boston, Massachusetts, with additional offices in Marlborough and Amherst. The firm focuses on investing in early-stage and growth-stage companies, particularly in the healthcare sector. LRVHealth specializes in technology-driven businesses, including software, digital health solutions, medical devices, diagnostics, and healthcare technology services. It seeks to provide capital ranging from $0.5 million to $5 million and typically prefers to co-invest while aiming for exits through trade sales. LRVHealth's network includes leading provider, payer, and vendor organizations, which enhances its ability to identify and support innovative solutions to pressing healthcare challenges. The firm's investments are primarily concentrated in the United States, particularly in Massachusetts.

Cowen, William R.

General Partner

Keith Figlioli

Managing Partner

Joshua Flum JD

Managing Partner

Ellen Herlacher

Principal

John Kole

Venture Partner

Tripp Peake

Co-Founder and Managing Partner

87 past transactions

Hellocare

Venture Round in 2025
Hellocare is a telehealth platform that offers a comprehensive virtual healthcare delivery system, integrating software, hardware, and artificial intelligence. The platform facilitates various services, including home care, primary care, virtual patient observation, and remote patient monitoring. It also provides remote examination kits, telemedicine carts, and tools for alerting, communications, and workflow management. By leveraging this technology, healthcare providers can deliver medical services from any location, enhancing accessibility and efficiency in patient care.

LucyRx

Seed Round in 2025
LucyRx is an independent, next-generation pharmacy benefit manager (PBM) that is transforming prescription care.

Lumata Health

Series B in 2025
Lumata Health is a technology-driven healthcare startup focused on preventing blindness from chronic eye conditions, managing thousands of people at risk of vision loss across the United States. Founded in 2017 by an ophthalmologist and retina specialist in practice for over 30 years, Stephen R. Fransen, MD, and supported by more than 30 industry luminaries and influencers on its Advisory Board, Lumata Health aims to stop preventable blindness with a human-led, intelligent care coordination and management platform that’s almost always free to the patient. The company partners with physicians, payers, and health systems to offer turnkey care management services provided by eye care experts who are supported by cutting-edge technology and data science. Lumata Health’s programs improve clinical outcomes, patient satisfaction, and clinic staff efficiency by providing between-visit patient assistance and care coordination for patients with chronic eye diseases such as diabetic retinopathy, macular degeneration, glaucoma, and dry eye.

Proximity

Seed Round in 2025
Proximity is a company that offers an automation platform aimed at improving revenue from the 340B drug discount program for eligible healthcare providers. The platform is designed to streamline processes and enhance efficiency, ultimately helping healthcare organizations maximize their benefits from this federal program intended to support safety-net providers in delivering affordable medications to underserved populations.

Sware

Series B in 2024
Sware offers a validation automation platform and managed services that focus on helping companies ensure compliance with both domestic and international regulatory requirements. The company develops enterprise-wide software that automates compliance processes, encompassing a range of services such as quality management implementation, risk management, auditing, training, and computer systems validation. By implementing these systems and utilizing an integrated compliance ecosystem methodology, Sware enables its clients to achieve greater product efficiency and reduce costs.

Huddle Up

Series C in 2024
Huddle Up operates as a pediatric digital health company dedicated to supporting the growth and mental health of children. Founded in 2015 and based in Madison, Wisconsin, the company offers a range of services, including speech therapy, occupational therapy, and mental health support, delivered through live, online interactions. Huddle Up emphasizes personalized care and outcome-driven approaches, partnering with school districts to enhance academic performance and promote social-emotional development. By fostering community, equity, inclusion, and belonging, the company aims to improve overall well-being and encourage healthier lifestyles among children and adolescents.

Greater Good Health

Series A in 2023
Greater Good Health is a healthcare organization focused on increasing access to value-based, holistic primary care, particularly in underserved and rural communities. Utilizing a Nurse Practitioner-led model, the organization collaborates with health plans to establish primary care practices and partners with risk-bearing organizations to implement private-labeled clinical programs. These initiatives aim to facilitate a transition to outcomes-focused care while enhancing patient experience. Greater Good Health's platform provides nurse practitioners with essential resources and tools to deliver quality, whole-person care, ultimately benefiting patients, providers, and payers alike by improving health outcomes and reducing overall costs.

Diana Health

Series B in 2023
Diana Health operates a network of contemporary women's health practices designed to enhance the delivery of maternity and women’s healthcare in collaboration with hospitals. The organization focuses on empowering women by offering personalized and comprehensive care that prioritizes their involvement in decision-making. Through an individualized care program, Diana Health integrates clinical care, education, and wellness support, all facilitated by a user-friendly technology platform. This approach aims to improve clinical outcomes and streamline operations, ultimately helping women prepare for childbirth and their parenting journeys.

Cortica

Series D in 2023
Cortica Inc. is an Israeli company established in 2007, specializing in advanced image understanding solutions through its proprietary AI technology. The company has developed its Image2Text technology, which enables computers to comprehend images and automatically generate contextual inventory from images and videos. This innovative approach allows Cortica's technology to extract and identify various concepts, including products, brands, and locations, mapping them to relevant keywords and taxonomies. Cortica's unique self-learning capabilities, supported by over 200 patents, enable it to achieve human-level image understanding, surpassing the capabilities of major tech companies. Its technology has applications across multiple industries, including autonomous vehicles, smart city initiatives, security, media, and medical analysis. By focusing on creating a "universal visual index of the world," Cortica aims to establish itself as a leader in the AI market for computer vision, embedding its capabilities into future platforms where image comprehension is essential. The company is headquartered in New York, with a significant research and development presence in Israel.

Cortica

Series D in 2023
Cortica Inc. is a healthcare company that specializes in providing neurological therapies for children with autism and other neurodevelopmental challenges. Founded in 2014 and based in San Diego, California, Cortica offers a range of services including diagnoses for autism, ADHD, developmental delays, and other developmental differences. The company's treatment approach is tailored to each child, based on a comprehensive understanding of their neurobiology and developmental profile. Cortica provides customized treatment programs through in-home, in-clinic, and telehealth services. Its offerings encompass various interventions such as gene sequencing, metabolic testing, electroencephalography, nutrition evaluation, medication management, and multiple therapeutic modalities including ABA therapy, speech-language therapy, occupational therapy, physical therapy, and music therapy. The company operates centers in several locations across California, including Carlsbad, Irvine, San Rafael, Torrance, and Westlake Village.

RxLightning

Series A in 2023
RxLightning is a digital platform focused on improving access to specialty medications by automating and streamlining the enrollment process. The company addresses the complexities associated with starting patients on specialty therapies across various fields, including addiction medicine, cardiology, endocrinology, and dermatology. By digitizing manual procedures, RxLightning reduces the burden of paperwork and enhances communication among healthcare providers, ultimately accelerating patients' speed to therapy. This innovative approach allows for a more efficient and effective management of specialty prescriptions, benefiting both healthcare professionals and patients alike.

Censinet

Venture Round in 2023
Censinet, Inc. is a healthcare-focused SaaS company that offers a cloud-based platform for managing third-party risk assessments. Founded in 2017 and based in Winchester, Massachusetts, Censinet connects healthcare providers with their vendors, streamlining the process of assessing and managing risks in real time. The platform eliminates the need for inefficient spreadsheets and manual workflows by automating risk assessments and providing continuous insights into vendor profiles. This approach enables healthcare organizations to identify and address potential threats within their vendor ecosystem effectively, enhancing overall cybersecurity and operational efficiency.
Upfront Healthcare Services, Inc. is a Chicago-based company that develops a data analytics platform aimed at improving the efficiency of physician practices in managing patient care. Founded in 2015, the company focuses on enhancing the ambulatory experience by automating and personalizing care navigation, which helps to engage patients effectively and optimize resource allocation. Its platform, known as Care Traffic Control, utilizes advanced analytics and personalized content to guide patients towards appropriate care options while addressing their specific needs. By offering insights derived from demographics, billing, scheduling, claims, and care gap data, Upfront Healthcare Services aims to increase appointment completion rates and improve health outcomes across healthcare systems.

KeyCare

Series A in 2022
KeyCare is a virtual care platform powered by Epic that was created to assist forward-thinking health systems in increasing patient access and quality by enhancing the alternatives available for virtual care.

Cleerly

Series C in 2022
Cleerly is a healthcare company whose mission is to create digital care pathways to prevent heart attacks. The company develops a new standard for coronary artery disease by integrating quality clinical science with the latest-generation AI, in order to offer actionable clinical insights to every stakeholder in the heart care pathway. Through these data-driven solutions, the company aims to provide a comprehensive solution for cardiovascular disease evaluation that offers value to the healthcare system and improves heart health for patients at risk of heart attacks.

Socially Determined

Series B in 2022
Socially Determined, Inc. develops a risk intelligence platform focused on social determinants of health (SDOH). Its primary offering, SocialScape, provides insights into social risks through a combination of social risk indices and visualizations derived from diverse data sources. This platform enables organizations, including health plans, providers, life science companies, and government agencies, to understand the dynamics of social risk and implement actionable programs aimed at enhancing health outcomes while reducing costs. Founded in 2017 and headquartered in Washington, D.C., Socially Determined utilizes secure, cloud-based technology to analyze and visualize community and individual SDOH risks, allowing clients to tailor their intervention strategies to address the specific needs of socially and clinically complex patients.

Greater Good Health

Series A in 2022
Greater Good Health is a healthcare organization focused on increasing access to value-based, holistic primary care, particularly in underserved and rural communities. Utilizing a Nurse Practitioner-led model, the organization collaborates with health plans to establish primary care practices and partners with risk-bearing organizations to implement private-labeled clinical programs. These initiatives aim to facilitate a transition to outcomes-focused care while enhancing patient experience. Greater Good Health's platform provides nurse practitioners with essential resources and tools to deliver quality, whole-person care, ultimately benefiting patients, providers, and payers alike by improving health outcomes and reducing overall costs.

Season Health

Series A in 2022
Season is a platform that offers personalized nutrition planning for consumers. It integrates technology with advice from users' registered dietitians to help them get more out of their nutrition and make the most out of mealtime every day. The platform recommends what to eat for breakfast, lunch, and dinner based on nutritional needs, food preferences, and budget.

Activ Surgical

Series B in 2022
Activ Surgical Inc. is a digital surgery company based in Boston, Massachusetts, focused on enhancing surgical efficiency, accuracy, and patient outcomes through advanced technology. Founded in 2014, the company has developed a robotic surgery platform that integrates computer vision, artificial intelligence, and robotics to assist surgeons during complex procedures. One of its key products is the Smart Tissue Autonomous Robot (STAR), which aims to revolutionize surgical practices by improving intraoperative decision-making and reducing the risk of unintended surgical complications. The platform is scalable and patent-protected, designed to support surgeons with augmented reality and data-driven insights, ultimately making surgeries safer and more effective.

Burns & Levinson

Series A in 2022
Burns & Levinson is a full-service law firm based in Boston, Massachusetts, established in 1960. The firm offers a wide range of legal services to regional, national, and international clients, focusing on areas such as business and finance, business litigation, family law, venture capital, employment, estate planning, intellectual property, private equity, and real estate. With expertise in corporate law and various sectors including automotive, cannabis, media, energy, clean-tech, industrials, life sciences, and sports, Burns & Levinson is committed to delivering client-centered, results-oriented solutions. The firm also provides services related to government investigations, white-collar criminal defense, tax, bankruptcy, lending and leasing, design and construction, and environmental law.

Story Health

Series A in 2022
Story Health Corporation, founded in 2020 and based in Saratoga, California, develops advanced virtualized clinical care software tools aimed at aiding healthcare specialists, particularly neurologists and primary care physicians. The company offers a comprehensive healthcare technology platform that includes virtual patient programs, therapy management, and analytics designed to bridge the gap between clinical evidence and patient experiences. By utilizing data from high-frequency sources, Story Health empowers clinicians to better understand medical situations and make informed decisions regarding the physiological impacts of diseases and therapies. Through its innovative approach, Story Health enhances the ability of specialists to deliver effective patient care.

Sware

Series A in 2022
Sware offers a validation automation platform and managed services that focus on helping companies ensure compliance with both domestic and international regulatory requirements. The company develops enterprise-wide software that automates compliance processes, encompassing a range of services such as quality management implementation, risk management, auditing, training, and computer systems validation. By implementing these systems and utilizing an integrated compliance ecosystem methodology, Sware enables its clients to achieve greater product efficiency and reduce costs.

Reimagine Care

Series A in 2022
Reimagine Care is a healthcare company focused on enhancing community-based oncology care through technology-enabled services. Established in 2020 and based in Nashville, Tennessee, the company seeks to improve the affordability, accessibility, and patient-centricity of cancer care. By collaborating with healthcare systems and independent oncology practices, Reimagine Care supports value-based oncology care delivery. Their approach involves providing the necessary personnel, processes, and a comprehensive technology platform that facilitates the effective and scalable delivery of high-quality cancer care at various locations, including patients' homes. This model aims to enable patients to receive treatment and supportive care in a more convenient and cost-effective manner.

Diana Health

Series A in 2022
Diana Health operates a network of contemporary women's health practices designed to enhance the delivery of maternity and women’s healthcare in collaboration with hospitals. The organization focuses on empowering women by offering personalized and comprehensive care that prioritizes their involvement in decision-making. Through an individualized care program, Diana Health integrates clinical care, education, and wellness support, all facilitated by a user-friendly technology platform. This approach aims to improve clinical outcomes and streamline operations, ultimately helping women prepare for childbirth and their parenting journeys.

Convergent Dental

Series C in 2021
Convergent Dental, Inc. is a dental equipment and technology company based in Needham, Massachusetts, established in 2011. The company specializes in developing Solea, a computer-aided CO2 laser system designed for both hard and soft tissue dental procedures. This innovative system aims to enhance the patient experience during dental surgeries by providing a quieter and more precise cutting mechanism compared to traditional laser systems. Utilizing patented technologies and advanced computer controls, Solea enables dentists to perform procedures more efficiently while minimizing discomfort for patients.

Activ Surgical

Series B in 2021
Activ Surgical Inc. is a digital surgery company based in Boston, Massachusetts, focused on enhancing surgical efficiency, accuracy, and patient outcomes through advanced technology. Founded in 2014, the company has developed a robotic surgery platform that integrates computer vision, artificial intelligence, and robotics to assist surgeons during complex procedures. One of its key products is the Smart Tissue Autonomous Robot (STAR), which aims to revolutionize surgical practices by improving intraoperative decision-making and reducing the risk of unintended surgical complications. The platform is scalable and patent-protected, designed to support surgeons with augmented reality and data-driven insights, ultimately making surgeries safer and more effective.

Huddle Up

Series A in 2021
Huddle Up operates as a pediatric digital health company dedicated to supporting the growth and mental health of children. Founded in 2015 and based in Madison, Wisconsin, the company offers a range of services, including speech therapy, occupational therapy, and mental health support, delivered through live, online interactions. Huddle Up emphasizes personalized care and outcome-driven approaches, partnering with school districts to enhance academic performance and promote social-emotional development. By fostering community, equity, inclusion, and belonging, the company aims to improve overall well-being and encourage healthier lifestyles among children and adolescents.

Genome Medical

Series C in 2021
Genome Medical, Inc. is a company based in South San Francisco, California, that specializes in genetic consultation and medical consulting services. Established in 2016, it operates a platform that connects individuals and healthcare providers to genetic specialists through its Genome Care Delivery technology. The company offers expert virtual genetic care across various clinical areas, including cancer, cardiovascular health, reproductive health, pediatrics, and pharmacy. By providing genetic assessments and personalized clinical action plans, Genome Medical enables patients to understand their genetic risks, make informed treatment decisions, and enhance overall health outcomes. The company aims to facilitate the integration of genomic medicine into everyday healthcare, assisting both patients and practitioners in navigating the complexities of genetic testing and its implications for disease diagnosis and management.

Main Street Health

Funding Round in 2021
Main Street Health is a provider of value-based, care-focused healthcare services aimed at addressing rural wellness concerns. The company's healthcare services are data-driven, and it provides partner clinics with employees, technology, critical access hospitals, community health centers, and possibilities to flourish in the care delivery model, allowing rural residents to receive the high-quality treatment they need.

Cleerly

Series B in 2021
Cleerly is a healthcare company whose mission is to create digital care pathways to prevent heart attacks. The company develops a new standard for coronary artery disease by integrating quality clinical science with the latest-generation AI, in order to offer actionable clinical insights to every stakeholder in the heart care pathway. Through these data-driven solutions, the company aims to provide a comprehensive solution for cardiovascular disease evaluation that offers value to the healthcare system and improves heart health for patients at risk of heart attacks.

Current Health

Series B in 2021
Current Health help healthcare reduces risk & cost by monitoring, managing, and engaging patients at home.

Carevive Systems

Series C in 2021
Carevive Systems, Inc. is a company that develops a platform designed to enhance cancer care delivery and patient engagement. The platform includes Carevive PROmpt, which serves as a cancer clinical practice and patient engagement software for treatment planning, symptom management, and survivorship care, as well as offering analytics and evidence-based care plans. It also features a Treatment Care Plans engine, which utilizes rules technology for personalized treatment strategies, and a Navigation/Care Coordination module that facilitates patient eligibility tracking and care plan adherence. Additionally, Carevive Systems provides tools for risk stratification, symptom triage, and patient symptom trending, allowing clinicians to monitor patient progress effectively. The company, based in North Miami, Florida, was incorporated in 2013 and rebranded from On Q Health, Inc. in 2015. Through its solutions, Carevive Systems aims to improve clinical outcomes and support oncology practices in adapting to value-based care models.

Diameter Health

Series B in 2020
Diameter Health transforms patient information into the quantity and quality of interoperable data for healthcare organizations. The core of the Diameter Health platform is Fusion, which enables intelligent data exchange ingestion and cleansing through sophisticated normalization and cleansing processes. Data originating from any certified Electronic Health Record (EHR) is transformed into clinical information optimized for use at the point of care or to be consumed as a rich substrate for analytics.
Upfront Healthcare Services, Inc. is a Chicago-based company that develops a data analytics platform aimed at improving the efficiency of physician practices in managing patient care. Founded in 2015, the company focuses on enhancing the ambulatory experience by automating and personalizing care navigation, which helps to engage patients effectively and optimize resource allocation. Its platform, known as Care Traffic Control, utilizes advanced analytics and personalized content to guide patients towards appropriate care options while addressing their specific needs. By offering insights derived from demographics, billing, scheduling, claims, and care gap data, Upfront Healthcare Services aims to increase appointment completion rates and improve health outcomes across healthcare systems.

Xealth

Venture Round in 2020
Xealth Inc. operates a digital health prescribing platform that allows clinicians to integrate, prescribe, and monitor digital health tools directly from electronic health record (EHR) workflows. Founded in 2016 and based in Seattle, Washington, the platform facilitates patient engagement by enabling care teams to order appropriate digital health tools and programs, which can be sent to patients via email or patient portals. In addition to managing digital health prescriptions, the platform supports patient education and offers non-clinical services such as ride shares and food delivery. This comprehensive approach allows clinicians to monitor patient activity and engagement, ultimately enhancing the overall effectiveness of digital health initiatives within healthcare systems.

Activ Surgical

Venture Round in 2020
Activ Surgical Inc. is a digital surgery company based in Boston, Massachusetts, focused on enhancing surgical efficiency, accuracy, and patient outcomes through advanced technology. Founded in 2014, the company has developed a robotic surgery platform that integrates computer vision, artificial intelligence, and robotics to assist surgeons during complex procedures. One of its key products is the Smart Tissue Autonomous Robot (STAR), which aims to revolutionize surgical practices by improving intraoperative decision-making and reducing the risk of unintended surgical complications. The platform is scalable and patent-protected, designed to support surgeons with augmented reality and data-driven insights, ultimately making surgeries safer and more effective.

Genome Medical

Series B in 2020
Genome Medical, Inc. is a company based in South San Francisco, California, that specializes in genetic consultation and medical consulting services. Established in 2016, it operates a platform that connects individuals and healthcare providers to genetic specialists through its Genome Care Delivery technology. The company offers expert virtual genetic care across various clinical areas, including cancer, cardiovascular health, reproductive health, pediatrics, and pharmacy. By providing genetic assessments and personalized clinical action plans, Genome Medical enables patients to understand their genetic risks, make informed treatment decisions, and enhance overall health outcomes. The company aims to facilitate the integration of genomic medicine into everyday healthcare, assisting both patients and practitioners in navigating the complexities of genetic testing and its implications for disease diagnosis and management.

SilverCloud Health

Series B in 2020
SilverCloud Health, founded in 2011 and based in Boston, Massachusetts, specializes in providing evidence-based digital therapies aimed at improving mental wellness. The company offers tailored online therapeutic solutions that address various mental health issues, enhancing overall emotional health. SilverCloud's platform has demonstrated significant success, achieving a three-fold increase in client engagement and a three-fold decrease in program dropout rates compared to leading online therapeutic products. By providing affordable and accessible digital health resources, SilverCloud Health aims to empower users to manage their mental health more effectively.

Carevive Systems

Series C in 2020
Carevive Systems, Inc. is a company that develops a platform designed to enhance cancer care delivery and patient engagement. The platform includes Carevive PROmpt, which serves as a cancer clinical practice and patient engagement software for treatment planning, symptom management, and survivorship care, as well as offering analytics and evidence-based care plans. It also features a Treatment Care Plans engine, which utilizes rules technology for personalized treatment strategies, and a Navigation/Care Coordination module that facilitates patient eligibility tracking and care plan adherence. Additionally, Carevive Systems provides tools for risk stratification, symptom triage, and patient symptom trending, allowing clinicians to monitor patient progress effectively. The company, based in North Miami, Florida, was incorporated in 2013 and rebranded from On Q Health, Inc. in 2015. Through its solutions, Carevive Systems aims to improve clinical outcomes and support oncology practices in adapting to value-based care models.

Socially Determined

Series A in 2019
Socially Determined, Inc. develops a risk intelligence platform focused on social determinants of health (SDOH). Its primary offering, SocialScape, provides insights into social risks through a combination of social risk indices and visualizations derived from diverse data sources. This platform enables organizations, including health plans, providers, life science companies, and government agencies, to understand the dynamics of social risk and implement actionable programs aimed at enhancing health outcomes while reducing costs. Founded in 2017 and headquartered in Washington, D.C., Socially Determined utilizes secure, cloud-based technology to analyze and visualize community and individual SDOH risks, allowing clients to tailor their intervention strategies to address the specific needs of socially and clinically complex patients.

Genome Medical

Series B in 2019
Genome Medical, Inc. is a company based in South San Francisco, California, that specializes in genetic consultation and medical consulting services. Established in 2016, it operates a platform that connects individuals and healthcare providers to genetic specialists through its Genome Care Delivery technology. The company offers expert virtual genetic care across various clinical areas, including cancer, cardiovascular health, reproductive health, pediatrics, and pharmacy. By providing genetic assessments and personalized clinical action plans, Genome Medical enables patients to understand their genetic risks, make informed treatment decisions, and enhance overall health outcomes. The company aims to facilitate the integration of genomic medicine into everyday healthcare, assisting both patients and practitioners in navigating the complexities of genetic testing and its implications for disease diagnosis and management.

Censinet

Series A in 2019
Censinet, Inc. is a healthcare-focused SaaS company that offers a cloud-based platform for managing third-party risk assessments. Founded in 2017 and based in Winchester, Massachusetts, Censinet connects healthcare providers with their vendors, streamlining the process of assessing and managing risks in real time. The platform eliminates the need for inefficient spreadsheets and manual workflows by automating risk assessments and providing continuous insights into vendor profiles. This approach enables healthcare organizations to identify and address potential threats within their vendor ecosystem effectively, enhancing overall cybersecurity and operational efficiency.

Diameter Health

Series A in 2019
Diameter Health transforms patient information into the quantity and quality of interoperable data for healthcare organizations. The core of the Diameter Health platform is Fusion, which enables intelligent data exchange ingestion and cleansing through sophisticated normalization and cleansing processes. Data originating from any certified Electronic Health Record (EHR) is transformed into clinical information optimized for use at the point of care or to be consumed as a rich substrate for analytics.
Verata Health, now part of Olive, was established in 2017 and is headquartered in Bloomington, Minnesota, with additional offices in Minneapolis, Boston, and Orlando. The company specializes in developing artificial intelligence-based software solutions aimed at improving the prior authorization process for healthcare providers and payers. Its platform synthesizes clinical documentation and medical necessity rules to provide real-time decision recommendations, thereby streamlining manual tasks and enhancing efficiency. By removing barriers associated with prior authorization, Verata Health's technology enables healthcare providers, private practices, and pharmacies to take control of their revenue cycles, reduce write-offs, and ensure that patients receive timely care. The company has gained trust from health systems and providers across the country for its innovative approach to modernizing the healthcare authorization process.

First Light Diagnostics

Series A in 2019
First Light Diagnostics Inc. specializes in the development of automated medical diagnostic products aimed at detecting microbes responsible for healthcare-associated infections. The company is known for its benchtop MultiPath analyzer, which identifies both resistant and sensitive strains of Staphylococcus aureus, as well as various toxins and viruses, making it suitable for hospital clinical microbiology laboratories. Its products address multiple applications, including the screening of blood, surgical, skin, and gastrointestinal infections. By offering rapid and cost-effective testing solutions, First Light Diagnostics meets the increasing demand for accurate diagnostics, which is essential for reducing hospital infection rates. The company's proprietary MultiPath detection technology combines the efficiency of advanced laboratory tests with affordability and ease of use. Founded in 2006 and based in Chelmsford, Massachusetts, First Light Diagnostics was previously known as First Light Biosciences until its name change in January 2019.

Cyft

Venture Round in 2019
Cyft partners with leading care organizations to optimize care management for chronic / complex, behavioral health, and dual-eligible populations. Cyft empowers Medicaid plans interested in moving beyond simplistic one size fits all approaches. By capitalizing on all available data to inform care management strategies, populate programs, and measure progress, Medicaid plans improve the health of both their members and their financials. Cyft is technology-enabled, using all relevant data - from claims to HRAs to case management notes - to match cost savings and revenue generating interventions to those most likely to benefit. However, real progress in care management is only ever achieved via a deep understanding of process and implementation of best practices. Toward that end, Cyft's team of healthcare experts works closely with partners to understand, design, and integrate results into existing systems and workflows. This high tech + high touch approach has helped 20+ plans capitalize on their existing data and talent to realize >$100M in cost savings and new revenue and improved member retainment and satisfaction.

MachineMetrics

Series A in 2018
MachineMetrics Inc. specializes in real-time production monitoring software tailored for manufacturing companies across various industries, including aerospace, automotive, and medical devices. Founded in 2014 and based in Northampton, Massachusetts, the company provides an automated cloud solution that collects, analyzes, and visualizes data from machines. Its platform enables real-time visibility into production processes through live dashboards and predictive notifications, allowing workers to address manufacturing issues promptly. By simplifying the integration of IoT technologies on the shop floor, MachineMetrics enhances manufacturing efficiency, reportedly improving productivity by over 20% for its clients. The company's focus on delivering actionable insights helps clients digitize legacy manufacturing processes and increase profitability.

IntelyCare

Series A in 2018
IntelyCare, Inc. is a healthcare staffing company based in Quincy, Massachusetts, founded in 2014. It provides an on-demand staffing platform that connects nursing professionals with post-acute healthcare facilities, enabling them to optimize staffing levels and manage workforce demands effectively. The platform allows nurses and nursing assistants to create their own schedules and select shifts that suit them, fostering a flexible work environment. Utilizing advanced data science and artificial intelligence, IntelyCare automates scheduling and improves the efficiency of filling nursing shifts, achieving rates three times the industry average. The company serves a variety of clients, including home care agencies, assisted living facilities, long-term care establishments, and rehabilitation hospitals, ultimately aiming to reduce burnout among nursing staff and enhance overall productivity. IntelyCare operates as a subsidiary of Leerink Revelation Healthcare Fund II GP, LLC.

Sansoro Health

Series B in 2018
Sansoro Health, Inc. is a healthcare technology company based in Minneapolis, Minnesota, that specializes in software solutions for electronic medical record (EMR) integration. Its primary product, Emissary, facilitates interoperability between various EMR systems by utilizing universal application programming interfaces (APIs) and a unified data model. Emissary allows for the integrated display of patient charts from multiple EMRs, offering real-time clinical analytics, as well as web and mobile application support. The software can be implemented quickly, often within hours, and is designed to connect with a wide range of third-party software and hardware, significantly reducing costs and complications for healthcare systems. Founded in 2014 and originally known as Sansoro Health, LLC, the company transitioned to its current name in July 2016 and operates as a subsidiary of Datica Health, Inc.

Oculus Health

Series A in 2017
Oculus Health provides the support, insights, and passion needed for primary care and specialty providers to be successful in a changing health care environment. They improve patient outcomes and bring joy back to the practice of medicine, all while growing your revenues.

MachineMetrics

Seed Round in 2016
MachineMetrics Inc. specializes in real-time production monitoring software tailored for manufacturing companies across various industries, including aerospace, automotive, and medical devices. Founded in 2014 and based in Northampton, Massachusetts, the company provides an automated cloud solution that collects, analyzes, and visualizes data from machines. Its platform enables real-time visibility into production processes through live dashboards and predictive notifications, allowing workers to address manufacturing issues promptly. By simplifying the integration of IoT technologies on the shop floor, MachineMetrics enhances manufacturing efficiency, reportedly improving productivity by over 20% for its clients. The company's focus on delivering actionable insights helps clients digitize legacy manufacturing processes and increase profitability.

Connotate

Series B in 2016
Connotate specializes in web data extraction and monitoring, providing a platform that addresses the challenges of converting web page content into usable data formats. The company’s patented intelligent Agent technology allows both business users and developers to efficiently create data sets and new applications. By enabling the harvesting, structuring, and monetization of web content, Connotate helps information product companies enhance their content extraction capabilities while lowering costs and simplifying their data operations. This results in increased productivity, reduced risks, and improved decision-making, ultimately offering clients strategic advantages in their respective markets.

Carevive Systems

Series B in 2016
Carevive Systems, Inc. is a company that develops a platform designed to enhance cancer care delivery and patient engagement. The platform includes Carevive PROmpt, which serves as a cancer clinical practice and patient engagement software for treatment planning, symptom management, and survivorship care, as well as offering analytics and evidence-based care plans. It also features a Treatment Care Plans engine, which utilizes rules technology for personalized treatment strategies, and a Navigation/Care Coordination module that facilitates patient eligibility tracking and care plan adherence. Additionally, Carevive Systems provides tools for risk stratification, symptom triage, and patient symptom trending, allowing clinicians to monitor patient progress effectively. The company, based in North Miami, Florida, was incorporated in 2013 and rebranded from On Q Health, Inc. in 2015. Through its solutions, Carevive Systems aims to improve clinical outcomes and support oncology practices in adapting to value-based care models.

MedCrypt

Seed Round in 2016
MedCrypt Inc. is a cybersecurity company focused on enhancing the security of medical devices. Founded in 2016 and based in Solana Beach, California, it provides data security solutions tailored for a wide range of medical devices, including pacemakers and surgical robots. MedCrypt's platform allows original equipment manufacturers (OEMs) to easily integrate essential security features, such as user authentication, data encryption, and monitoring for potential malicious activity, into their devices. This capability not only protects sensitive health information but also ensures that devices operate only on commands from trusted sources. By streamlining the implementation of these security measures, MedCrypt enables engineers to prioritize the development of innovative clinical functionalities while maintaining robust protection against unauthorized access and misuse.

Diameter Health

Series A in 2016
Diameter Health transforms patient information into the quantity and quality of interoperable data for healthcare organizations. The core of the Diameter Health platform is Fusion, which enables intelligent data exchange ingestion and cleansing through sophisticated normalization and cleansing processes. Data originating from any certified Electronic Health Record (EHR) is transformed into clinical information optimized for use at the point of care or to be consumed as a rich substrate for analytics.

lifeIMAGE

Series D in 2015
LifeIMAGE is an online network that enables individuals to exchange medical images. LifeIMAGE is interoperable with the hospital EMR to provide integrated access to medical images, from anywhere. Clinicians can exchange medical images with patients and providers, anywhere. It was founded in 2008 and headquartered in Newton, Massachusetts.

MachineMetrics

Venture Round in 2015
MachineMetrics Inc. specializes in real-time production monitoring software tailored for manufacturing companies across various industries, including aerospace, automotive, and medical devices. Founded in 2014 and based in Northampton, Massachusetts, the company provides an automated cloud solution that collects, analyzes, and visualizes data from machines. Its platform enables real-time visibility into production processes through live dashboards and predictive notifications, allowing workers to address manufacturing issues promptly. By simplifying the integration of IoT technologies on the shop floor, MachineMetrics enhances manufacturing efficiency, reportedly improving productivity by over 20% for its clients. The company's focus on delivering actionable insights helps clients digitize legacy manufacturing processes and increase profitability.

lifeIMAGE

Venture Round in 2015
LifeIMAGE is an online network that enables individuals to exchange medical images. LifeIMAGE is interoperable with the hospital EMR to provide integrated access to medical images, from anywhere. Clinicians can exchange medical images with patients and providers, anywhere. It was founded in 2008 and headquartered in Newton, Massachusetts.

Convergent Dental

Venture Round in 2015
Convergent Dental, Inc. is a dental equipment and technology company based in Needham, Massachusetts, established in 2011. The company specializes in developing Solea, a computer-aided CO2 laser system designed for both hard and soft tissue dental procedures. This innovative system aims to enhance the patient experience during dental surgeries by providing a quieter and more precise cutting mechanism compared to traditional laser systems. Utilizing patented technologies and advanced computer controls, Solea enables dentists to perform procedures more efficiently while minimizing discomfort for patients.

Convergent Dental

Venture Round in 2014
Convergent Dental, Inc. is a dental equipment and technology company based in Needham, Massachusetts, established in 2011. The company specializes in developing Solea, a computer-aided CO2 laser system designed for both hard and soft tissue dental procedures. This innovative system aims to enhance the patient experience during dental surgeries by providing a quieter and more precise cutting mechanism compared to traditional laser systems. Utilizing patented technologies and advanced computer controls, Solea enables dentists to perform procedures more efficiently while minimizing discomfort for patients.

lifeIMAGE

Series B in 2011
LifeIMAGE is an online network that enables individuals to exchange medical images. LifeIMAGE is interoperable with the hospital EMR to provide integrated access to medical images, from anywhere. Clinicians can exchange medical images with patients and providers, anywhere. It was founded in 2008 and headquartered in Newton, Massachusetts.

Phreesia

Series D in 2010
Phreesia is a privately held company that specializes in enhancing the patient check-in process in healthcare settings. By introducing the PhreesiaPad, a wireless touchscreen device, the company replaces traditional check-in methods, allowing patients to securely provide their health information in a HIPAA-compliant manner. This technology integrates seamlessly with existing electronic medical records and does not disrupt physician workflows. Phreesia's platform offers a comprehensive suite of solutions that includes patient access, registration, appointment scheduling, payments, and post-appointment surveys, aimed at improving operational efficiency and financial performance for healthcare organizations. Additionally, the company focuses on enriching the patient experience by providing relevant health education and allowing patients to verify previously recorded information. Phreesia is supported by prominent venture capital firms and has raised $13.25 million to date to further its initiatives in patient care and wellness.

MedVentive

Series C in 2010
MedVentive provides leading-edge technology solutions that enable physician groups, integrated delivery systems, health plans and self-insured employers to effect meaningful and measurable change in the quality and cost of the care they deliver to patients. Founded in 1997 by physicians, MedVentive has been at the forefront of the development of innovative and clinically sophisticated solutions to reduce healthcare costs and improve healthcare quality.

Phreesia

Series D in 2010
Phreesia is a privately held company that specializes in enhancing the patient check-in process in healthcare settings. By introducing the PhreesiaPad, a wireless touchscreen device, the company replaces traditional check-in methods, allowing patients to securely provide their health information in a HIPAA-compliant manner. This technology integrates seamlessly with existing electronic medical records and does not disrupt physician workflows. Phreesia's platform offers a comprehensive suite of solutions that includes patient access, registration, appointment scheduling, payments, and post-appointment surveys, aimed at improving operational efficiency and financial performance for healthcare organizations. Additionally, the company focuses on enriching the patient experience by providing relevant health education and allowing patients to verify previously recorded information. Phreesia is supported by prominent venture capital firms and has raised $13.25 million to date to further its initiatives in patient care and wellness.

Solais Lighting

Series A in 2010
Solais Lighting is a manufacturing company specializing in energy-efficient LED lighting solutions aimed at enhancing various environments, including retail, supermarkets, commercial spaces, museums, and hospitality venues. As a leader in LED lamp technology, Solais focuses on innovation to meet market demands, utilizing advanced techniques such as active cooling to prolong the lifespan and performance of its products while maintaining aesthetic appeal. The company benefits from a skilled executive team with extensive experience across the lighting industry, encompassing research, product development, and manufacturing. With strong financial backing, Solais is well-positioned to grow and adapt to evolving market needs while leveraging a global manufacturing partner to ensure quality and responsiveness in its operations.

GateRocket

Series A in 2009
GateRocket, Inc. provides verification and debugging solutions for FPGAs. It offers RocketDrive, a device native verification system for complex FPGAs, which accelerates verification throughput and identifies problems with IP blocks, pin-outs, and tool chain anomalies. The company also provides RocketVision, a FPGA debug solution that automates test point insertion and detects differences between RTL and FPGA devices. The company was incorporated in 2003 and is headquartered in Bedford, Massachusetts.

lifeIMAGE

Series A in 2009
LifeIMAGE is an online network that enables individuals to exchange medical images. LifeIMAGE is interoperable with the hospital EMR to provide integrated access to medical images, from anywhere. Clinicians can exchange medical images with patients and providers, anywhere. It was founded in 2008 and headquartered in Newton, Massachusetts.

Health Guru Media Inc.

Series C in 2009
Healthguru.com is the destination site for health video on the web with 99 million views per month (comScore Video Metrix, August). Our unique approach to health education was developed specifically for the video audience and is differentiated in three key ways: - Category Focus: Healthguru.com focuses on the health topics that matter most to today's audience, including: diet and fitness, mental & emotional health, sexual health, pregnancy, baby health, drugs & alcohol, as well as information on more than 125 different health conditions. - Medium: The modern health consumer seeks out an immersive, rich media experience on the web, and video has proven to be a more engaging medium. Healthguru.com has the largest health video library online, and interactive applications to offer our audience the experience it expects. - Editorial Approach: World-class information providers know that creating truly engaging content is the way to ensure that information becomes learning. That's why Healthguru.com is dedicated to making our content as interesting and, when relevant, entertaining, as it is useful. All Healthguru.com content is created or selected by our editorial team and is rigorously reviewed for medical accuracy, objectivity and balance. While we do accept advertising on our site and may distribute content via third party sites, Healthguru.com does not endorse products, services or companies.

MedVentive

Series C in 2009
MedVentive provides leading-edge technology solutions that enable physician groups, integrated delivery systems, health plans and self-insured employers to effect meaningful and measurable change in the quality and cost of the care they deliver to patients. Founded in 1997 by physicians, MedVentive has been at the forefront of the development of innovative and clinically sophisticated solutions to reduce healthcare costs and improve healthcare quality.

Phreesia

Series C in 2009
Phreesia is a privately held company that specializes in enhancing the patient check-in process in healthcare settings. By introducing the PhreesiaPad, a wireless touchscreen device, the company replaces traditional check-in methods, allowing patients to securely provide their health information in a HIPAA-compliant manner. This technology integrates seamlessly with existing electronic medical records and does not disrupt physician workflows. Phreesia's platform offers a comprehensive suite of solutions that includes patient access, registration, appointment scheduling, payments, and post-appointment surveys, aimed at improving operational efficiency and financial performance for healthcare organizations. Additionally, the company focuses on enriching the patient experience by providing relevant health education and allowing patients to verify previously recorded information. Phreesia is supported by prominent venture capital firms and has raised $13.25 million to date to further its initiatives in patient care and wellness.

Qteros

Series B in 2008
Qteros (formerly SunEthanol) is an emerging biofuels company focused on microbe technology. The scientists and energy experts are unlocking the sugars from trees, plants, and other plentiful nonfood biomass. With the Q Microbe, they will transform eco-friendly biomass into cellulosic ethanol more efficiently than with any other technology available today. Because the process starts with a naturally occurring, renewable microbe, it is simple, clean, and very close to being carbon-neutral. Once they apply the technology on a commercial scale, locally produced transportation fuel will be cheaper, cleaner, and sustainable as long as the sun keeps shining.

GateRocket

Series A in 2008
GateRocket, Inc. provides verification and debugging solutions for FPGAs. It offers RocketDrive, a device native verification system for complex FPGAs, which accelerates verification throughput and identifies problems with IP blocks, pin-outs, and tool chain anomalies. The company also provides RocketVision, a FPGA debug solution that automates test point insertion and detects differences between RTL and FPGA devices. The company was incorporated in 2003 and is headquartered in Bedford, Massachusetts.

MedVentive

Series B in 2008
MedVentive provides leading-edge technology solutions that enable physician groups, integrated delivery systems, health plans and self-insured employers to effect meaningful and measurable change in the quality and cost of the care they deliver to patients. Founded in 1997 by physicians, MedVentive has been at the forefront of the development of innovative and clinically sophisticated solutions to reduce healthcare costs and improve healthcare quality.

Phreesia

Series B in 2007
Phreesia is a privately held company that specializes in enhancing the patient check-in process in healthcare settings. By introducing the PhreesiaPad, a wireless touchscreen device, the company replaces traditional check-in methods, allowing patients to securely provide their health information in a HIPAA-compliant manner. This technology integrates seamlessly with existing electronic medical records and does not disrupt physician workflows. Phreesia's platform offers a comprehensive suite of solutions that includes patient access, registration, appointment scheduling, payments, and post-appointment surveys, aimed at improving operational efficiency and financial performance for healthcare organizations. Additionally, the company focuses on enriching the patient experience by providing relevant health education and allowing patients to verify previously recorded information. Phreesia is supported by prominent venture capital firms and has raised $13.25 million to date to further its initiatives in patient care and wellness.

Qteros

Series A in 2007
Qteros (formerly SunEthanol) is an emerging biofuels company focused on microbe technology. The scientists and energy experts are unlocking the sugars from trees, plants, and other plentiful nonfood biomass. With the Q Microbe, they will transform eco-friendly biomass into cellulosic ethanol more efficiently than with any other technology available today. Because the process starts with a naturally occurring, renewable microbe, it is simple, clean, and very close to being carbon-neutral. Once they apply the technology on a commercial scale, locally produced transportation fuel will be cheaper, cleaner, and sustainable as long as the sun keeps shining.

Phreesia

Series A in 2006
Phreesia is a privately held company that specializes in enhancing the patient check-in process in healthcare settings. By introducing the PhreesiaPad, a wireless touchscreen device, the company replaces traditional check-in methods, allowing patients to securely provide their health information in a HIPAA-compliant manner. This technology integrates seamlessly with existing electronic medical records and does not disrupt physician workflows. Phreesia's platform offers a comprehensive suite of solutions that includes patient access, registration, appointment scheduling, payments, and post-appointment surveys, aimed at improving operational efficiency and financial performance for healthcare organizations. Additionally, the company focuses on enriching the patient experience by providing relevant health education and allowing patients to verify previously recorded information. Phreesia is supported by prominent venture capital firms and has raised $13.25 million to date to further its initiatives in patient care and wellness.

MedVentive

Series A in 2006
MedVentive provides leading-edge technology solutions that enable physician groups, integrated delivery systems, health plans and self-insured employers to effect meaningful and measurable change in the quality and cost of the care they deliver to patients. Founded in 1997 by physicians, MedVentive has been at the forefront of the development of innovative and clinically sophisticated solutions to reduce healthcare costs and improve healthcare quality.

Optasite

Series B in 2005
Optasite engages in the acquisition and development of telecommunications tower sites in the United States. It offers wireless consulting services. The company's services also include site leasing and colocation, tower acquisition, and site development. It serves broadband wireless providers, including wireless carriers, as well as other customers in the telecommunications industry, such as the FCC licensed carriers, government agencies, public safety organizations, private enterprises, and two-way radio services. Optasite, Inc. was formerly known as Pinnacle Site Development, Inc

GetWellNetwork

Series B in 2005
GetWellNetwork, Inc. is a company that specializes in developing interactive software solutions aimed at enhancing patient engagement in healthcare settings. Founded in 1999 and based in Bethesda, Maryland, the company provides a range of products including a patient care model that combines technology and processes to activate patient involvement in their care. Key offerings include digital patient check-in, integrated entertainment and educational resources for patients, and personalized care solutions that deliver real-time information to healthcare providers. The company's platform also features a patient engagement index to assess individual patient capacities and customizable digital rounding tools for healthcare teams. By utilizing bedside technology, GetWellNetwork aims to create a more patient-centered care experience, offering educational content tailored to specific health conditions while also providing entertainment options. The company serves a diverse clientele, including healthcare providers, pediatric hospitals, and government organizations, with an overarching goal of improving patient outcomes and overall satisfaction in the care continuum.

Verax Biomedical

Series B in 2005
Verax Biomedical was founded upon the singular vision of detecting bacterial contamination in cells and tissues intended for transfusion and transplantation. Recognizing that bacteria pose a unique infectious challenge in these life-giving tissues, they realized that novel approaches to detection were called for. While these cellular materials are routinely tested for viral contaminants, bacteria have posed a long-standing and heretofore poorly addressed challenge. Unlike viruses, bacteria can replicate outside of a living host, meaning they can grow in these cellular matrices during storage prior to transfusion or transplantation. This results in the unique dilemma of an infectious contaminant that can grow from unmeasurably low levels at the time of collection to massive levels at the time of transfusion or transplantation, posing a serious and often fatal risk to their recipient.

Aircuity

Series C in 2005
Aircuity manufactures integrated sensing and control solutions that cost-effectively reduce building energy and operating expenses while simultaneously improving its indoor environmental quality. Aircuity's first product, a portable air monitoring system known as OptimaTM, it was developed in collaboration with Environmental Health & Engineering, the primary research contractor for the EPA's Indoor Environments Division. It was incorporated in 2000 and is headquartered in Newton, Massachusetts.

Aircuity

Series C in 2004
Aircuity manufactures integrated sensing and control solutions that cost-effectively reduce building energy and operating expenses while simultaneously improving its indoor environmental quality. Aircuity's first product, a portable air monitoring system known as OptimaTM, it was developed in collaboration with Environmental Health & Engineering, the primary research contractor for the EPA's Indoor Environments Division. It was incorporated in 2000 and is headquartered in Newton, Massachusetts.

Optasite

Series A in 2004
Optasite engages in the acquisition and development of telecommunications tower sites in the United States. It offers wireless consulting services. The company's services also include site leasing and colocation, tower acquisition, and site development. It serves broadband wireless providers, including wireless carriers, as well as other customers in the telecommunications industry, such as the FCC licensed carriers, government agencies, public safety organizations, private enterprises, and two-way radio services. Optasite, Inc. was formerly known as Pinnacle Site Development, Inc

Medical Metrx Solutions

Series B in 2003
Medical Metrx Solutions, Inc. (formerly Medical Media Systems) is a medical technology and services company providing diagnostic quality 3-D virtual models of patient anatomy built from CT and MR scan data using the company’s proprietary modeling software. The company’s models — which contain more precise quantitative measurement information than competitors’ offerings — are provided to interventional radiologists and vascular surgeons who use them for pre-operative planning and post-operative surveillance of their patients’ conditions. The company was acquired by AIG Altaris Health Partners in 2005.

Protedyne

Venture Round in 2001
In May 2007, Protedyne became a wholly owned subsidiary of Laboratory Corporation of America www.labcorp.com. Protedyne brings serious laboratory automation to LabCorp’s diagnostic testing facilities nationwide. Using the design principles of industrial automation, Protedyne’s automation systems combine powerful laboratory robotic hardware with a software infrastructure that ensures complete data management and process tracking. Protedyne is ISO 13485:2003 Registered with BSI Management Systems.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.